LINC 2026: Mainstage Symposium and Live Case Insights
Read More
San Clemente, CA – April 23, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, today announced the U.S. market launch of…
Read More
San Clemente, CA – April 13, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces that12-month results from the DEEPER…
Read More
Fellows and young physicians gained practical experience in real anatomy during October's Practical Vascular Trainee Lab (PVTL), led by Kumar Madassery, MD, and supported by Reflow Medical’s dedicated education station.…
Read More
In Chicago, we proudly celebrated the U.S. launch of the Breakthrough Device, Spur Peripheral Retrievable Stent System, a milestone for Reflow Medical and BTK treatment. One highlight was our dedicated…
Read More
San Clemente, CA – September 29, 2025 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER…
Read More
Spur® Peripheral Retrievable Stent System Receives FDA De NovoClearance We’re proud to announce that our first-of-its-kind Spur Stent System is now commercially available in the U.S. Featuring innovative Spur technology,…
Read More
In the past 12 months, we’ve signed 25 new distribution agreements with strong, strategic partners located outside of the U.S. who understand our mission and are ready to amplify it.…
Read More
San Clemente, CA – May 29, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug…
Read More
San Clemente, CA – March 6, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary…
Read More
Recent Comments